Colorectal Cancer Trial, Recruiting NCT06952101 Sponsor: Fondazione del Piemonte per l'Oncologia Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06952101
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who are able to read and sign a consent form agreeing to take part in the trial
  • People who have a high-risk early-stage rectal cancer (called pT1 rectal adenocarcinoma) that has already been removed by an endoscopic procedure
  • People who have a specific stage of rectal cancer (called cT2-3aN0) and have shown a complete or major response to an experimental form of chemotherapy and radiation treatment
  • People who have a more advanced stage of rectal cancer (called cT3b4N0-1) and have shown a complete or major response to a standard form of chemotherapy and radiation treatment

Who may not be able to join:

  • People with certain stages of rectal cancer (classified as cT2-4 any NM0) who have not achieved a complete or major response after completing either the experimental or standard chemotherapy and radiation treatment
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Felice Borghi, MD, Fondazione del Piemonte per l'Oncologia

Phone: +390119933445

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione del Piemonte per l'Oncologia
Registry
ClinicalTrials.gov
Start date
30 April 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Development and Validation of a Clinical-Radiologic-Molecular Scoring System for Predicting Pathologic Complete Response (pCR) in Rectal Cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov